Antimycobacterial activity of rifampicin.
D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D005069:Evaluation Studies as Topic; D006168:Guinea Pigs; D006801:Humans; D008168:Lung / Q000382:microbiology; D051379:Mice; D008826:Microbial Sensitivity Tests; D009161:Mycobacterium / Q000187:drug effects* / Q000302:isolation & purification; D009163:Mycobacterium bovis / Q000187:drug effects; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009929:Organ Size; D012293:Rifampin / Q000494:pharmacology* / Q000627:therapeutic use; D013154:Spleen / Q000187:drug effects; D013183:Sputum / Q000382:microbiology; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D004338:Drug Combinations; D012293:Rifampin